Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer
Authors:
- 14 September 2015
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 35 (20) , 2645-2654
Abstract
MUC4, a large transmembrane mucin normally expressed in the small and large intestine, is differentially expressed during inflammatory and malignant conditions of the colon. However, the expression pattern and the role of MUC4 in colitis and colorectal cancer (CRC) are inconclusive. Therefore, the aim of this study was to understand the role of Muc4 during inflammatory and malignant conditions of the colon. Here, we generated Muc4−/− mice and addressed its role in colitis and colitis-associated CRC using dextran sodium sulfate (DSS) and azoxymethane (AOM)-DSS experimental models, respectively. Muc4−/− mice were viable, fertile with no apparent defects. Muc4−/− mice displayed increased resistance to DSS-induced colitis compared with wild-type (WT) littermates that was evaluated by survival rate, body weight loss, diarrhea and fecal blood score, and histological score. Reduced infiltration of inflammatory cells, that is, CD3+ lymphocytes and F4/80+ macrophages was observed in the inflamed mucosa along with reduction in the mRNA levels of inflammatory cytokines interleukin (IL)-1β and tumor necrosis factor (TNF)-α and anti-microbial genes Lysozyme M and SLPI in the colon of Muc4−/− mice compared with WT littermates. Compensatory upregulation of Muc2 and Muc3 mucins under basal and DSS treatment conditions partly explains the resistance observed in Muc4−/− mice. Accordingly, Muc4−/− mice exhibited significantly reduced tumor burden compared with WT mice assessed in a colitis-induced tumor model using AOM/DSS. An increased percentage of Ki67+ nuclei was observed in the tumors from WT compared with Muc4−/− mice suggesting Muc4 to be critical in intestinal cell proliferation during tumorigenesis. Taken together, we conclusively demonstrate for the first time the role of Muc4 in driving intestinal inflammation and inflammation-associated tumorigenesis using a novel Muc4−/− mouse model.Keywords
This publication has 51 references indexed in Scilit:
- Mucins in the pathogenesis of breast cancer: Implications in diagnosis, prognosis and therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2011
- Mucin dynamics and enteric pathogensNature Reviews Microbiology, 2011
- MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cellsOncogene, 2010
- Prognostic value of mucin 4 expression in colorectal adenocarcinomasCancer, 2010
- Activity of recombinant cysteine-rich domain proteins derived from the membrane-bound MUC17/Muc3 family mucinsBiochimica et Biophysica Acta (BBA) - General Subjects, 2010
- Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitisThe International Journal of Biochemistry & Cell Biology, 2010
- Mucin-interacting proteins: from function to therapeuticsTrends in Biochemical Sciences, 2010
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancerBritish Journal of Cancer, 2008
- Structure, evolution, and biology of the MUC4 mucinThe FASEB Journal, 2007